title: Reply to "Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs".
authors.affiliation: Department of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
authors.forename: Amanda Fortes
authors.initials: AF
authors.lastname: Francisco
authors.affiliation: Department of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
authors.forename: Michael D
authors.initials: MD
authors.lastname: Lewis
authors.affiliation: Department of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
authors.forename: Shiromani
authors.initials: S
authors.lastname: Jayawardhana
authors.affiliation: Department of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
authors.forename: Martin C
authors.initials: MC
authors.lastname: Taylor
authors.affiliation: Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland.
authors.forename: Eric
authors.initials: E
authors.lastname: Chatelain
authors.affiliation: Department of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom john.kelly@lshtm.ac.uk.
authors.forename: John M
authors.initials: JM
authors.lastname: Kelly
mesh_terms: D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology*; D014355:Chagas Disease / Q000188:drug therapy*; D002908:Chronic Disease / Q000188:drug therapy*; D005260:Female; D014230:Triazoles / Q000494:pharmacology*; D014344:Trypanocidal Agents / Q000494:pharmacology*; D014349:Trypanosoma cruzi / Q000187:drug effects*
chemical_list: D000935:Antifungal Agents; D014230:Triazoles; D014344:Trypanocidal Agents